SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

HSBC Raises Gilead Sciences Price Target to $190 From $175

HSBC adjusted its price target on Gilead Sciences to $190 from $175. MT Newswires reports the company has an average rating of overweight.

GILD

Related stories